tiprankstipranks
OS Therapies announces OST-HER2 trial achieves primary endpoint
PremiumThe FlyOS Therapies announces OST-HER2 trial achieves primary endpoint
15d ago
OS Therapies to sell 1.5M units at $4.00 in private placement
Premium
The Fly
OS Therapies to sell 1.5M units at $4.00 in private placement
1M ago
OS Therapies initiated with a Buy at Maxim
Premium
The Fly
OS Therapies initiated with a Buy at Maxim
2M ago
OS Therapies announces efficacy, safety data for ovarian cancer candidate
PremiumThe FlyOS Therapies announces efficacy, safety data for ovarian cancer candidate
5M ago
OS Therapies initiated with a Buy at EF Hutton
Premium
The Fly
OS Therapies initiated with a Buy at EF Hutton
5M ago
OS Therapies: Last patient in OST-HER2  Osteosarcoma trial gest last dose
Premium
The Fly
OS Therapies: Last patient in OST-HER2 Osteosarcoma trial gest last dose
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100